A phase 1-2 study of imexon plus dacarbazine in patients with unresectable metastatic melanoma

Jeffrey S. Weber, Wolfram E. Samlowski, Rene Gonzalez, Antoni Ribas, Joe Stephenson, Steven O'Day, Takami Sato, Robert Dorr, Kathryn Grenier, Evan Hersh

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 1-2 study of imexon plus dacarbazine in patients with unresectable metastatic melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences